Dermatology Drug Industry Research Report 2024
Summary
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
According to APO Research, The global Dermatology Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dermatology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Drug.
The Dermatology Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Dermatology Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
According to APO Research, The global Dermatology Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dermatology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Drug.
The Dermatology Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- AbbVie
- Johnson & Johnson
- Bayer
- Galderma
- Bristol-Myers Squibb
- Novartis
- Pfizer
- Merz Pharma
- Valeant
- LEO Pharma
- GlaxoSmithKline
- External Use
- Oral
- Injection
- Psoriasis
- Skin Infections
- Acne
- Dermatitis
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Dermatology Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Dermatology Drug by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 External Use
2.2.3 Oral
2.2.4 Injection
2.3 Dermatology Drug by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Psoriasis
2.3.3 Skin Infections
2.3.4 Acne
2.3.5 Dermatitis
2.3.6 Others
2.4 Assumptions and Limitations
3 DERMATOLOGY DRUG BREAKDOWN DATA BY TYPE
3.1 Global Dermatology Drug Historic Market Size by Type (2019-2024)
3.2 Global Dermatology Drug Forecasted Market Size by Type (2025-2030)
4 DERMATOLOGY DRUG BREAKDOWN DATA BY APPLICATION
4.1 Global Dermatology Drug Historic Market Size by Application (2019-2024)
4.2 Global Dermatology Drug Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Dermatology Drug Market Perspective (2019-2030)
5.2 Global Dermatology Drug Growth Trends by Region
5.2.1 Global Dermatology Drug Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Dermatology Drug Historic Market Size by Region (2019-2024)
5.2.3 Dermatology Drug Forecasted Market Size by Region (2025-2030)
5.3 Dermatology Drug Market Dynamics
5.3.1 Dermatology Drug Industry Trends
5.3.2 Dermatology Drug Market Drivers
5.3.3 Dermatology Drug Market Challenges
5.3.4 Dermatology Drug Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Dermatology Drug Players by Revenue
6.1.1 Global Top Dermatology Drug Players by Revenue (2019-2024)
6.1.2 Global Dermatology Drug Revenue Market Share by Players (2019-2024)
6.2 Global Dermatology Drug Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Dermatology Drug Head office and Area Served
6.4 Global Dermatology Drug Players, Product Type & Application
6.5 Global Dermatology Drug Players, Date of Enter into This Industry
6.6 Global Dermatology Drug Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Dermatology Drug Market Size (2019-2030)
7.2 North America Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Dermatology Drug Market Size by Country (2019-2024)
7.4 North America Dermatology Drug Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Dermatology Drug Market Size (2019-2030)
8.2 Europe Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Dermatology Drug Market Size by Country (2019-2024)
8.4 Europe Dermatology Drug Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Dermatology Drug Market Size (2019-2030)
9.2 Asia-Pacific Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Dermatology Drug Market Size by Country (2019-2024)
9.4 Asia-Pacific Dermatology Drug Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Dermatology Drug Market Size (2019-2030)
10.2 Latin America Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Dermatology Drug Market Size by Country (2019-2024)
10.4 Latin America Dermatology Drug Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Dermatology Drug Market Size (2019-2030)
11.2 Middle East & Africa Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Dermatology Drug Market Size by Country (2019-2024)
11.4 Middle East & Africa Dermatology Drug Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 AbbVie
12.1.1 AbbVie Company Information
12.1.2 AbbVie Business Overview
12.1.3 AbbVie Revenue in Dermatology Drug Business (2019-2024)
12.1.4 AbbVie Dermatology Drug Product Portfolio
12.1.5 AbbVie Recent Developments
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Revenue in Dermatology Drug Business (2019-2024)
12.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
12.2.5 Johnson & Johnson Recent Developments
12.3 Bayer
12.3.1 Bayer Company Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Revenue in Dermatology Drug Business (2019-2024)
12.3.4 Bayer Dermatology Drug Product Portfolio
12.3.5 Bayer Recent Developments
12.4 Galderma
12.4.1 Galderma Company Information
12.4.2 Galderma Business Overview
12.4.3 Galderma Revenue in Dermatology Drug Business (2019-2024)
12.4.4 Galderma Dermatology Drug Product Portfolio
12.4.5 Galderma Recent Developments
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Information
12.5.2 Bristol-Myers Squibb Business Overview
12.5.3 Bristol-Myers Squibb Revenue in Dermatology Drug Business (2019-2024)
12.5.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
12.5.5 Bristol-Myers Squibb Recent Developments
12.6 Novartis
12.6.1 Novartis Company Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Revenue in Dermatology Drug Business (2019-2024)
12.6.4 Novartis Dermatology Drug Product Portfolio
12.6.5 Novartis Recent Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Revenue in Dermatology Drug Business (2019-2024)
12.7.4 Pfizer Dermatology Drug Product Portfolio
12.7.5 Pfizer Recent Developments
12.8 Merz Pharma
12.8.1 Merz Pharma Company Information
12.8.2 Merz Pharma Business Overview
12.8.3 Merz Pharma Revenue in Dermatology Drug Business (2019-2024)
12.8.4 Merz Pharma Dermatology Drug Product Portfolio
12.8.5 Merz Pharma Recent Developments
12.9 Valeant
12.9.1 Valeant Company Information
12.9.2 Valeant Business Overview
12.9.3 Valeant Revenue in Dermatology Drug Business (2019-2024)
12.9.4 Valeant Dermatology Drug Product Portfolio
12.9.5 Valeant Recent Developments
12.10 LEO Pharma
12.10.1 LEO Pharma Company Information
12.10.2 LEO Pharma Business Overview
12.10.3 LEO Pharma Revenue in Dermatology Drug Business (2019-2024)
12.10.4 LEO Pharma Dermatology Drug Product Portfolio
12.10.5 LEO Pharma Recent Developments
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Company Information
12.11.2 GlaxoSmithKline Business Overview
12.11.3 GlaxoSmithKline Revenue in Dermatology Drug Business (2019-2024)
12.11.4 GlaxoSmithKline Dermatology Drug Product Portfolio
12.11.5 GlaxoSmithKline Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Dermatology Drug by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 External Use
2.2.3 Oral
2.2.4 Injection
2.3 Dermatology Drug by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Psoriasis
2.3.3 Skin Infections
2.3.4 Acne
2.3.5 Dermatitis
2.3.6 Others
2.4 Assumptions and Limitations
3 DERMATOLOGY DRUG BREAKDOWN DATA BY TYPE
3.1 Global Dermatology Drug Historic Market Size by Type (2019-2024)
3.2 Global Dermatology Drug Forecasted Market Size by Type (2025-2030)
4 DERMATOLOGY DRUG BREAKDOWN DATA BY APPLICATION
4.1 Global Dermatology Drug Historic Market Size by Application (2019-2024)
4.2 Global Dermatology Drug Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Dermatology Drug Market Perspective (2019-2030)
5.2 Global Dermatology Drug Growth Trends by Region
5.2.1 Global Dermatology Drug Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Dermatology Drug Historic Market Size by Region (2019-2024)
5.2.3 Dermatology Drug Forecasted Market Size by Region (2025-2030)
5.3 Dermatology Drug Market Dynamics
5.3.1 Dermatology Drug Industry Trends
5.3.2 Dermatology Drug Market Drivers
5.3.3 Dermatology Drug Market Challenges
5.3.4 Dermatology Drug Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Dermatology Drug Players by Revenue
6.1.1 Global Top Dermatology Drug Players by Revenue (2019-2024)
6.1.2 Global Dermatology Drug Revenue Market Share by Players (2019-2024)
6.2 Global Dermatology Drug Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Dermatology Drug Head office and Area Served
6.4 Global Dermatology Drug Players, Product Type & Application
6.5 Global Dermatology Drug Players, Date of Enter into This Industry
6.6 Global Dermatology Drug Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Dermatology Drug Market Size (2019-2030)
7.2 North America Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Dermatology Drug Market Size by Country (2019-2024)
7.4 North America Dermatology Drug Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Dermatology Drug Market Size (2019-2030)
8.2 Europe Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Dermatology Drug Market Size by Country (2019-2024)
8.4 Europe Dermatology Drug Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Dermatology Drug Market Size (2019-2030)
9.2 Asia-Pacific Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Dermatology Drug Market Size by Country (2019-2024)
9.4 Asia-Pacific Dermatology Drug Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Dermatology Drug Market Size (2019-2030)
10.2 Latin America Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Dermatology Drug Market Size by Country (2019-2024)
10.4 Latin America Dermatology Drug Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Dermatology Drug Market Size (2019-2030)
11.2 Middle East & Africa Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Dermatology Drug Market Size by Country (2019-2024)
11.4 Middle East & Africa Dermatology Drug Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 AbbVie
12.1.1 AbbVie Company Information
12.1.2 AbbVie Business Overview
12.1.3 AbbVie Revenue in Dermatology Drug Business (2019-2024)
12.1.4 AbbVie Dermatology Drug Product Portfolio
12.1.5 AbbVie Recent Developments
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Revenue in Dermatology Drug Business (2019-2024)
12.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
12.2.5 Johnson & Johnson Recent Developments
12.3 Bayer
12.3.1 Bayer Company Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Revenue in Dermatology Drug Business (2019-2024)
12.3.4 Bayer Dermatology Drug Product Portfolio
12.3.5 Bayer Recent Developments
12.4 Galderma
12.4.1 Galderma Company Information
12.4.2 Galderma Business Overview
12.4.3 Galderma Revenue in Dermatology Drug Business (2019-2024)
12.4.4 Galderma Dermatology Drug Product Portfolio
12.4.5 Galderma Recent Developments
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Information
12.5.2 Bristol-Myers Squibb Business Overview
12.5.3 Bristol-Myers Squibb Revenue in Dermatology Drug Business (2019-2024)
12.5.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
12.5.5 Bristol-Myers Squibb Recent Developments
12.6 Novartis
12.6.1 Novartis Company Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Revenue in Dermatology Drug Business (2019-2024)
12.6.4 Novartis Dermatology Drug Product Portfolio
12.6.5 Novartis Recent Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Revenue in Dermatology Drug Business (2019-2024)
12.7.4 Pfizer Dermatology Drug Product Portfolio
12.7.5 Pfizer Recent Developments
12.8 Merz Pharma
12.8.1 Merz Pharma Company Information
12.8.2 Merz Pharma Business Overview
12.8.3 Merz Pharma Revenue in Dermatology Drug Business (2019-2024)
12.8.4 Merz Pharma Dermatology Drug Product Portfolio
12.8.5 Merz Pharma Recent Developments
12.9 Valeant
12.9.1 Valeant Company Information
12.9.2 Valeant Business Overview
12.9.3 Valeant Revenue in Dermatology Drug Business (2019-2024)
12.9.4 Valeant Dermatology Drug Product Portfolio
12.9.5 Valeant Recent Developments
12.10 LEO Pharma
12.10.1 LEO Pharma Company Information
12.10.2 LEO Pharma Business Overview
12.10.3 LEO Pharma Revenue in Dermatology Drug Business (2019-2024)
12.10.4 LEO Pharma Dermatology Drug Product Portfolio
12.10.5 LEO Pharma Recent Developments
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Company Information
12.11.2 GlaxoSmithKline Business Overview
12.11.3 GlaxoSmithKline Revenue in Dermatology Drug Business (2019-2024)
12.11.4 GlaxoSmithKline Dermatology Drug Product Portfolio
12.11.5 GlaxoSmithKline Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Dermatology Drug Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Dermatology Drug Revenue Market Share by Type (2018-2023)
Table 7. Global Dermatology Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Dermatology Drug Revenue Market Share by Type (2024-2029)
Table 9. Global Dermatology Drug Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Dermatology Drug Revenue Market Share by Application (2018-2023)
Table 11. Global Dermatology Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Dermatology Drug Revenue Market Share by Application (2024-2029)
Table 13. Global Dermatology Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Dermatology Drug Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Dermatology Drug Market Share by Region (2018-2023)
Table 16. Global Dermatology Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Dermatology Drug Market Share by Region (2024-2029)
Table 18. Dermatology Drug Market Trends
Table 19. Dermatology Drug Market Drivers
Table 20. Dermatology Drug Market Challenges
Table 21. Dermatology Drug Market Restraints
Table 22. Global Top Dermatology Drug Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Dermatology Drug Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Dermatology Drug Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Dermatology Drug, Headquarters and Area Served
Table 26. Global Dermatology Drug Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Dermatology Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. AbbVie Company Detail
Table 46. AbbVie Business Overview
Table 47. AbbVie Dermatology Drug Product
Table 48. AbbVie Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 49. AbbVie Recent Development
Table 50. Johnson & Johnson Company Detail
Table 51. Johnson & Johnson Business Overview
Table 52. Johnson & Johnson Dermatology Drug Product
Table 53. Johnson & Johnson Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 54. Johnson & Johnson Recent Development
Table 55. Bayer Company Detail
Table 56. Bayer Business Overview
Table 57. Bayer Dermatology Drug Product
Table 58. Bayer Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 59. Bayer Recent Development
Table 60. Galderma Company Detail
Table 61. Galderma Business Overview
Table 62. Galderma Dermatology Drug Product
Table 63. Galderma Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 64. Galderma Recent Development
Table 65. Bristol-Myers Squibb Company Detail
Table 66. Bristol-Myers Squibb Business Overview
Table 67. Bristol-Myers Squibb Dermatology Drug Product
Table 68. Bristol-Myers Squibb Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 69. Bristol-Myers Squibb Recent Development
Table 70. Novartis Company Detail
Table 71. Novartis Business Overview
Table 72. Novartis Dermatology Drug Product
Table 73. Novartis Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Pfizer Company Detail
Table 76. Pfizer Business Overview
Table 77. Pfizer Dermatology Drug Product
Table 78. Pfizer Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Merz Pharma Company Detail
Table 81. Merz Pharma Business Overview
Table 82. Merz Pharma Dermatology Drug Product
Table 83. Merz Pharma Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 84. Merz Pharma Recent Development
Table 85. Valeant Company Detail
Table 86. Valeant Business Overview
Table 87. Valeant Dermatology Drug Product
Table 88. Valeant Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 89. Valeant Recent Development
Table 90. LEO Pharma Company Detail
Table 91. LEO Pharma Business Overview
Table 92. LEO Pharma Dermatology Drug Product
Table 93. LEO Pharma Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 94. LEO Pharma Recent Development
Table 95. GlaxoSmithKline Company Detail
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Dermatology DrugProduct
Table 98. GlaxoSmithKline Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 99. GlaxoSmithKline Recent Development
Table 100. AbbVie Company Information
Table 101. AbbVie Business Overview
Table 102. AbbVie Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 103. AbbVie Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 104. AbbVie Recent Development
Table 105. Johnson & Johnson Company Information
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 108. Johnson & Johnson Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 109. Johnson & Johnson Recent Development
Table 110. Bayer Company Information
Table 111. Bayer Business Overview
Table 112. Bayer Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 113. Bayer Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 114. Bayer Recent Development
Table 115. Galderma Company Information
Table 116. Galderma Business Overview
Table 117. Galderma Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 118. Galderma Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 119. Galderma Recent Development
Table 120. Bristol-Myers Squibb Company Information
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 123. Bristol-Myers Squibb Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 124. Bristol-Myers Squibb Recent Development
Table 125. Novartis Company Information
Table 126. Novartis Business Overview
Table 127. Novartis Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 128. Novartis Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 129. Novartis Recent Development
Table 130. Pfizer Company Information
Table 131. Pfizer Business Overview
Table 132. Pfizer Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 133. Pfizer Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 134. Pfizer Recent Development
Table 135. Merz Pharma Company Information
Table 136. Merz Pharma Business Overview
Table 137. Merz Pharma Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 138. Merz Pharma Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 139. Merz Pharma Recent Development
Table 140. Valeant Company Information
Table 141. Valeant Business Overview
Table 142. Valeant Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 143. Valeant Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 144. Valeant Recent Development
Table 145. LEO Pharma Company Information
Table 146. LEO Pharma Business Overview
Table 147. LEO Pharma Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 148. LEO Pharma Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 149. LEO Pharma Recent Development
Table 150. GlaxoSmithKline Company Information
Table 151. GlaxoSmithKline Business Overview
Table 152. GlaxoSmithKline Dermatology DrugRevenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 153. GlaxoSmithKline Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 154. GlaxoSmithKline Recent Development
Table 155. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Dermatology Drug Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Dermatology Drug Revenue Market Share by Type (2018-2023)
Table 7. Global Dermatology Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Dermatology Drug Revenue Market Share by Type (2024-2029)
Table 9. Global Dermatology Drug Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Dermatology Drug Revenue Market Share by Application (2018-2023)
Table 11. Global Dermatology Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Dermatology Drug Revenue Market Share by Application (2024-2029)
Table 13. Global Dermatology Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Dermatology Drug Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Dermatology Drug Market Share by Region (2018-2023)
Table 16. Global Dermatology Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Dermatology Drug Market Share by Region (2024-2029)
Table 18. Dermatology Drug Market Trends
Table 19. Dermatology Drug Market Drivers
Table 20. Dermatology Drug Market Challenges
Table 21. Dermatology Drug Market Restraints
Table 22. Global Top Dermatology Drug Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Dermatology Drug Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Dermatology Drug Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Dermatology Drug, Headquarters and Area Served
Table 26. Global Dermatology Drug Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Dermatology Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Dermatology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Dermatology Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Dermatology Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. AbbVie Company Detail
Table 46. AbbVie Business Overview
Table 47. AbbVie Dermatology Drug Product
Table 48. AbbVie Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 49. AbbVie Recent Development
Table 50. Johnson & Johnson Company Detail
Table 51. Johnson & Johnson Business Overview
Table 52. Johnson & Johnson Dermatology Drug Product
Table 53. Johnson & Johnson Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 54. Johnson & Johnson Recent Development
Table 55. Bayer Company Detail
Table 56. Bayer Business Overview
Table 57. Bayer Dermatology Drug Product
Table 58. Bayer Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 59. Bayer Recent Development
Table 60. Galderma Company Detail
Table 61. Galderma Business Overview
Table 62. Galderma Dermatology Drug Product
Table 63. Galderma Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 64. Galderma Recent Development
Table 65. Bristol-Myers Squibb Company Detail
Table 66. Bristol-Myers Squibb Business Overview
Table 67. Bristol-Myers Squibb Dermatology Drug Product
Table 68. Bristol-Myers Squibb Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 69. Bristol-Myers Squibb Recent Development
Table 70. Novartis Company Detail
Table 71. Novartis Business Overview
Table 72. Novartis Dermatology Drug Product
Table 73. Novartis Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Pfizer Company Detail
Table 76. Pfizer Business Overview
Table 77. Pfizer Dermatology Drug Product
Table 78. Pfizer Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Merz Pharma Company Detail
Table 81. Merz Pharma Business Overview
Table 82. Merz Pharma Dermatology Drug Product
Table 83. Merz Pharma Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 84. Merz Pharma Recent Development
Table 85. Valeant Company Detail
Table 86. Valeant Business Overview
Table 87. Valeant Dermatology Drug Product
Table 88. Valeant Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 89. Valeant Recent Development
Table 90. LEO Pharma Company Detail
Table 91. LEO Pharma Business Overview
Table 92. LEO Pharma Dermatology Drug Product
Table 93. LEO Pharma Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 94. LEO Pharma Recent Development
Table 95. GlaxoSmithKline Company Detail
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Dermatology DrugProduct
Table 98. GlaxoSmithKline Revenue in Dermatology Drug Business (2017-2022) & (US$ Million)
Table 99. GlaxoSmithKline Recent Development
Table 100. AbbVie Company Information
Table 101. AbbVie Business Overview
Table 102. AbbVie Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 103. AbbVie Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 104. AbbVie Recent Development
Table 105. Johnson & Johnson Company Information
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 108. Johnson & Johnson Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 109. Johnson & Johnson Recent Development
Table 110. Bayer Company Information
Table 111. Bayer Business Overview
Table 112. Bayer Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 113. Bayer Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 114. Bayer Recent Development
Table 115. Galderma Company Information
Table 116. Galderma Business Overview
Table 117. Galderma Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 118. Galderma Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 119. Galderma Recent Development
Table 120. Bristol-Myers Squibb Company Information
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 123. Bristol-Myers Squibb Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 124. Bristol-Myers Squibb Recent Development
Table 125. Novartis Company Information
Table 126. Novartis Business Overview
Table 127. Novartis Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 128. Novartis Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 129. Novartis Recent Development
Table 130. Pfizer Company Information
Table 131. Pfizer Business Overview
Table 132. Pfizer Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 133. Pfizer Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 134. Pfizer Recent Development
Table 135. Merz Pharma Company Information
Table 136. Merz Pharma Business Overview
Table 137. Merz Pharma Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 138. Merz Pharma Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 139. Merz Pharma Recent Development
Table 140. Valeant Company Information
Table 141. Valeant Business Overview
Table 142. Valeant Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 143. Valeant Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 144. Valeant Recent Development
Table 145. LEO Pharma Company Information
Table 146. LEO Pharma Business Overview
Table 147. LEO Pharma Dermatology Drug Revenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 148. LEO Pharma Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 149. LEO Pharma Recent Development
Table 150. GlaxoSmithKline Company Information
Table 151. GlaxoSmithKline Business Overview
Table 152. GlaxoSmithKline Dermatology DrugRevenue in Dermatology Drug Business (2018-2023) & (US$ Million)
Table 153. GlaxoSmithKline Revenue in Dermatology Drug Business (2018-2023) & (US$ Million) Portfolio
Table 154. GlaxoSmithKline Recent Development
Table 155. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Dermatology Drug Product Picture
Figure 5. Global Dermatology Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Dermatology Drug Market Share by Type: 2022 VS 2029
Figure 7. External Use Product Picture
Figure 8. Oral Product Picture
Figure 9. Injection Product Picture
Figure 10. Global Dermatology Drug Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Dermatology Drug Market Share by Application: 2022 VS 2029
Figure 12. Psoriasis Product Picture
Figure 13. Skin Infections Product Picture
Figure 14. Acne Product Picture
Figure 15. Dermatitis Product Picture
Figure 16. Others Product Picture
Figure 17. Global Dermatology Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Dermatology Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Dermatology Drug Market Share by Region: 2022 VS 2029
Figure 20. Global Dermatology Drug Market Share by Players in 2022
Figure 21. Global Dermatology Drug Players, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Dermatology Drug Players Market Share by Revenue in 2022
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. North America Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Dermatology Drug Market Share by Country (2018-2029)
Figure 26. United States Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Dermatology Drug Market Share by Country (2018-2029)
Figure 30. Germany Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Dermatology Drug Market Share by Country (2018-2029)
Figure 38. China Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Dermatology Drug Market Share by Country (2018-2029)
Figure 46. Mexico Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Dermatology Drug Market Share by Country (2018-2029)
Figure 50. Turkey Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. UAE Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. AbbVie Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 54. Johnson & Johnson Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 55. Bayer Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 56. Galderma Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 58. Novartis Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 60. Merz Pharma Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 61. Valeant Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 62. LEO Pharma Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Dermatology Drug Product Picture
Figure 5. Global Dermatology Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Dermatology Drug Market Share by Type: 2022 VS 2029
Figure 7. External Use Product Picture
Figure 8. Oral Product Picture
Figure 9. Injection Product Picture
Figure 10. Global Dermatology Drug Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Dermatology Drug Market Share by Application: 2022 VS 2029
Figure 12. Psoriasis Product Picture
Figure 13. Skin Infections Product Picture
Figure 14. Acne Product Picture
Figure 15. Dermatitis Product Picture
Figure 16. Others Product Picture
Figure 17. Global Dermatology Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Dermatology Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Dermatology Drug Market Share by Region: 2022 VS 2029
Figure 20. Global Dermatology Drug Market Share by Players in 2022
Figure 21. Global Dermatology Drug Players, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Dermatology Drug Players Market Share by Revenue in 2022
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. North America Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Dermatology Drug Market Share by Country (2018-2029)
Figure 26. United States Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Dermatology Drug Market Share by Country (2018-2029)
Figure 30. Germany Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Dermatology Drug Market Share by Country (2018-2029)
Figure 38. China Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Dermatology Drug Market Share by Country (2018-2029)
Figure 46. Mexico Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Dermatology Drug Market Share by Country (2018-2029)
Figure 50. Turkey Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. UAE Dermatology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. AbbVie Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 54. Johnson & Johnson Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 55. Bayer Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 56. Galderma Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 58. Novartis Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 60. Merz Pharma Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 61. Valeant Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 62. LEO Pharma Revenue Growth Rate in Dermatology Drug Business (2018-2023)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Dermatology Drug Business (2018-2023)
